Enjoy a Better Life - Tips and Tools 

clinical

[9] Young BA.

[9] Young BA, diabetes and kidney disease in Veterans.[10] Novartis data on file. Controlled[11] Garber A, Effects of vildagliptin on glucose control in patients with type 2 diabetes insufficiently with a sulphonylurea -. Diabetes, Obesity and Metabolism 2008; 10:1326-1463.

Separately reinforced an analysis of pooled data from over 1,400 patients that Galvus in type 2 diabetic patients with mild to moderate renal tolerated[3]. Decreased renal function is more common in patients with type 2 diabetes[8], with the prevalence of kidney disease by 20-40 percent[9]. The analysis also confirmed there were no adverse changes in renal function after long-term treatment with Galvus[3]. Similar efficacy was achieved in patients with mild renal impairment and those with normal renal function[3]. Galvus is currently patients with moderate or patients with moderate or severe renal impairment in Europe. Continue reading